Anti-thrombotic agents derived from snake venom proteins
- PMID: 27766044
- PMCID: PMC5056499
- DOI: 10.1186/s12959-016-0113-1
Anti-thrombotic agents derived from snake venom proteins
Abstract
Snake venoms affect blood coagulation and platelet function in a complex manner. However, two classes of venom proteins, snaclecs and disintegrins have been shown to specifically target receptors including GPIb, α2β1, GPVI, CLEC-2 and integrins αIIbβ3, αvβ3, α5β1 expressed on platelets, endothelial cells, phagocytes, tumor cells, thus affecting cell-matrices and cell-cell interactions. Here, we focus on disintegrins, a class of low molecular mass Arg-Gly-Asp(RGD)/Lys-Gly-Asp(KGD)-containing, cysteine-rich polypeptide derived from various viper snake venoms. This review describes the potential applications of disintegrins in field of integrin-related diseases, especially arterial thrombosis, angiogenesis, tumor progression and septic inflammation. In addition, a novel RGD-containing disintegrin TMV-7 is being developed as a safer antithrombotic agent with minimal side effects, such as thrombocytopenia and bleeding.
Keywords: Angiogenesis; Antithrombotic agent; Arterial thrombosis; Disintegrins; Septic inflammation; Snake venom proteins.
References
-
- Ginsberg MH, Loftus JC, Plow EF. Cytoadhesins, integrins, and platelets. Thromb Haemost. 1988;59:1–6. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
